Stock Scorecard



Stock Summary for Aadi Bioscience Inc (AADI) - $1.75 as of 4/26/2024 4:20:24 PM EST

Total Score

13 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AADI

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AADI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AADI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for AADI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for AADI

Is Aadi Bioscience ( AADI ) Stock Outpacing Its Medical Peers This Year? 4/3/2024 1:40:00 PM
Is Aadi Bioscience ( AADI ) Outperforming Other Medical Stocks This Year? 3/18/2024 1:40:00 PM
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology ( SGO ) 3/17/2024 12:00:00 PM
Aadi Bioscience, Inc. ( AADI ) Reports Q4 Loss, Misses Revenue Estimates 3/13/2024 1:05:00 PM
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update 3/13/2024 12:00:00 PM
NGM Biopharmaceuticals ( NGM ) Reports Q4 Loss, Lags Revenue Estimates 3/11/2024 9:30:00 PM
Evogene ( EVGN ) Reports Q4 Loss, Misses Revenue Estimates 3/7/2024 2:20:00 PM
Ocuphire ( OCUP ) to Report Q4 Earnings: What's in the Cards? 3/4/2024 1:18:00 PM
Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket - Adial Pharmaceuticals ( NASDAQ:ADIL ) , Aadi Bioscience ( NASDAQ:AADI ) 3/4/2024 1:04:00 PM
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa 3/1/2024 9:08:00 PM

Financial Details for AADI

Company Overview

Ticker AADI
Company Name Aadi Bioscience Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 6/13/2024

Stock Price History

Last Day Price 1.75
Last Day Price Updated 4/26/2024 4:20:24 PM EST
Last Day Volume 147,678
Average Daily Volume 216,042
52-Week High 8.60
52-Week Low 1.55
Last Price to 52 Week Low 12.90%

Valuation Measures

Trailing PE N/A
Industry PE 79.17
Sector PE 56.64
5-Year Average PE -3.03
Free Cash Flow Ratio 0.40
Industry Free Cash Flow Ratio 12.71
Sector Free Cash Flow Ratio 30.65
Current Ratio Most Recent Quarter 4.72
Total Cash Per Share 4.43
Book Value Per Share Most Recent Quarter 4.28
Price to Book Ratio 0.46
Industry Price to Book Ratio 5.66
Sector Price to Book Ratio 22.15
Price to Sales Ratio Twelve Trailing Months 1.98
Industry Price to Sales Ratio Twelve Trailing Months 5.48
Sector Price to Sales Ratio Twelve Trailing Months 5.17

Share Statistics

Total Shares Outstanding 24,554,200
Market Capitalization 42,969,850
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -8.74%
Reported EPS 12 Trailing Months -2.44
Reported EPS Past Year 0.00
Reported EPS Prior Year -2.44
Net Income Twelve Trailing Months -65,794,000
Net Income Past Year -65,800,000
Net Income Prior Year -60,513,000
Quarterly Revenue Growth YOY 21.00%
5-Year Revenue Growth 3.66%

Balance Sheet

Total Cash Most Recent Quarter 108,800,000
Total Cash Past Year 108,800,000
Total Cash Prior Year 172,600,000
Net Cash Position Most Recent Quarter 108,800,000
Net Cash Position Past Year 108,800,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 105,195,000
Total Stockholder Equity Prior Year 158,378,000
Total Stockholder Equity Most Recent Quarter 105,195,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.10
MACD Signal -0.07
20-Day Bollinger Lower Band 1.53
20-Day Bollinger Middle Band 1.95
20-Day Bollinger Upper Band 2.36
Beta 0.30
RSI 32.56
50-Day SMA 4.40
200-Day SMA 15.38

System

Modified 4/26/2024 4:20:25 PM EST